Inventor

Jorg Czech

Inventor

Marburg, DE

Overview

18→

Patents

1993–2007

Patent span

Human necessities

Primary field (CPC A)

Patents· 18 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes23%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%

C07HSugars9%

B82YSpecific uses or applications of nanostructures8%

C07KPeptides8%

C12NMicroorganisms or enzymes6%

C12YEnzymes6%

A01KAnimal husbandry3%

C07CAcyclic or carbocyclic compounds3%

C07DHeterocyclic compounds3%

PatentTitleYear

7,273,727'Fusion proteins for prodrug activation'2007 7,241,595'Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates'2007 7,060,495'Fusion proteins for prodrug activation'2006 6,610,299'Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates'2003 6,475,486'Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates'2002 6,146,658'Prodrugs, their preparation and use as pharmaceuticals'2000 6,020,315'Preparation having increased in vivo tolerability'2000 6,020,372'Use of isoxazole and crotonamide derivatives for the treatment of carcinomatous disorders'2000 5,955,100'Prodrugs their preparation and use as pharmaceuticals'1999 5,935,995'Prodrugs for the therapy of tumors and inflammatory disorders'1999 5,886,033'Use of isoxazole and crotonamide derivatives for the treatment of carcinomatous disorders'1999 5,877,158'Pro-prodrugs, their production and use'1999 5,817,800'Inhibitors of .beta.-glucuronidase and their use in the treatment of carcinamatosis and inflammation'1998 5,710,134'Combination of necrosis-inducing substances with substances which are activated by necroses for the selective therapy of tumors and inflammatory disorders'1998 5,621,002'Prodrugs for enzyme mediated activation'1997 5,561,119'Glycosylated prodrugs, their method of preparation and their uses'1996 5,519,018'Substituted phenols and their use for the treatment of disorders caused by cell proliferation'1996 5,189,065'Use of derivatives of 9,10-dihydrophenanthrene for the preparation of an anti-tumor medicament'1993

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1993–2007Based in Marburg, DE· patent location history

1996–2006Patents assigned to BEHRINGWERKE AG (7)· patent assignee history

1997–1999Patents assigned to HOECHST SA LAB (3)· patent assignee history

1998–2000Patents assigned to HOECHST AG (6)· patent assignee history

2002–2003Patents assigned to AVENTIS PHARMA GMBH (2)· patent assignee history

2007Patents assigned to BEHRINWERKE AG (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
BEHRINGWERKE AG	7	1996–2006
HOECHST AG	6	1998–2000
HOECHST SA LAB	3	1997–1999
AVENTIS PHARMA GMBH	2	2002–2003
BEHRINWERKE AG	1	2007

Locations

Location	Patents	Span
Marburg, DE	18	1993–2007